文献速递睡眠呼吸障碍

CPAP治疗对阻塞性睡眠呼吸暂停患者血压影响的全球个体患者数据荟萃分析

Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis.
PubMed 文献 · Eur Respir J · 2025-01-02

该个体患者数据荟萃分析纳入36项随机对照试验共9434例成人OSA患者,比较CPAP与被动或主动治疗对血压的影响。结果显示CPAP仅使基线未控制血压者收缩压降低2.6 mmHg、舒张压降低1.7 mmHg,而基线血压控制者无显著获益,提示基线血压未控制者从CPAP治疗中血压获益最大。

要点

  • CPAP仅对基线未控制血压的OSA患者有显著降压作用。
  • 基线血压控制者CPAP治疗未见血压降低。
  • 年龄和夜间缺氧程度对CPAP降压效果的影响不一致或无差异。

核心结论

  • CPAP治疗对基线血压未控制的OSA患者降压获益最大,对基线血压已控制者无显著降压效果。

研究设计与样本

  • 系统检索比较CPAP与被动或主动治疗的随机对照试验,纳入成人OSA患者(AHI>5次·h-1)且CPAP前后测量血压。
  • 共纳入36项平行研究,9434例患者。

主要发现

  • 基线未控制诊室收缩压者CPAP治疗后收缩压降低2.6 mmHg,基线控制者降低0 mmHg(p<0.0001)。
  • 基线未控制舒张压者CPAP治疗后舒张压降低1.7 mmHg,基线控制者降低1 mmHg(p=0.091)。
  • 年龄≤60岁与>60岁患者血压变化差异仅在多重插补后可见(收缩压p=0.0127,舒张压p=0.017)。
  • 有无严重夜间缺氧患者之间血压降低无差异。

临床怎么用

  • 对于合并高血压的OSA患者,若基线血压未控制,CPAP治疗可能带来额外降压获益。
  • 基线血压已控制的OSA患者,CPAP的降压作用有限,决策时应综合考虑其他获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obstructive sleep apnoea (OSA) is associated with hypertension, and OSA treatment can reduce systolic blood pressure (SBP) and diastolic blood pressure (DBP), but with a modest mean effect size and vast heterogeneity among studies. The aim of this individual patient data (IPD) meta-analysis was to understand which OSA phenotypes could benefit the most in terms of BP reduction. METHODS: A systematic review of randomised controlled trials that compared continuous positive airway pressure (CPAP) with either passive or active treatment was conducted. Studies were eligible if they included adult patients with OSA diagnosed by full polysomnography or cardiorespiratory polygraphy (defined as apnoea-hypopnoea index >5 events·h-1) and if BP was measured both before and after CPAP treatment. RESULTS: In total, 36 parallel studies (n=9434 patients) were included. CPAP treatment was associated with BP reduction in patients with uncontrolled office SBP only, while BP was not reduced by CPAP in patients with controlled BP (SBP -2.6 versus 0 mmHg; p<0.0001; DBP -1.7 versus -1 mmHg; p=0.091). Differences were seen also when BP changes were compared between patients aged ≤60 versus >60 years after multiple imputation only (p=0.0127 for SBP and p=0.017 for DBP). No differences were seen in terms of BP reduction when comparing patients with/without severe nocturnal hypoxia. CONCLUSIONS: This IPD meta-analysis of the BP effects of OSA treatment with CPAP shows that OSA patients with uncontrolled BP at baseline benefit the most from CPAP therapy in terms of BP reduction. These results have important implications for the decision on how to best manage arterial hypertension associated with OSA.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Pengo MF, Schwarz EI, Barbé F, et al. Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis. Eur Respir J. 2025. PMID: 39401854. doi:10.1183/13993003.00837-2024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。